NeurologyLive® Friday 5 — April 10, 2026

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

Click the read more or watch now buttons for more details and information about each highlight.

1: Q1 2026 Clinical Recap: 7 FDA-Approved Treatments for Neurologists to Know

Stay informed on the latest therapeutic advancements in neurology with this exclusive clinical recap from the NeurologyLive team, featuring a centralized look at 7 FDA-approved treatments from the first quarter of 2026.

2: Key Takeaways and Implications of the 2026 Stroke Guidelines

In this episode of our latest NeurologyLive Roundtable Discussion, Beth Cavanaugh, MD, and Andrei Alexandrov, MD, discussed key takeaways in the latest ischemic stroke guidelines, including the transition toward tenecteplase, advances in multimodal imaging, and growing attention to pediatric stroke care. [WATCH TIME: 3 minutes]

3: Advances in Hunter Syndrome Therapeutics: Overviewing the Pipeline

Following the FDA approval of tividenofusp alfa, this NeurologyLive exclusive feature explored the evolving Hunter syndrome treatment landscape and highlights key pipeline therapies targeting both systemic and central nervous system disease burden.

4: NeuroVoice: Kaitlyn Palmer, MD, on Lasting Takeaways From the 2026 ACTRIMS Forum

In our latest NeuroVoices Q&A, Kaitlyn Palmer, MD, a neuroimmunology fellow at the Cleveland Clinic, shared her experience attending the 2026 ACTRIMS Forum, specifically focusing on the late-breaking data presented in multiple sclerosis.

5: Rethinking Parkinson Care: The Role of High-Intensity Inpatient Rehabilitation

In a recent Q&A, Steven Markos, MD, a physician at Hackensack Meridian JFK Johnson Rehabilitation Institute, discussed a 2-week inpatient rehabilitation program and its impact on functional and speech outcomes in Parkinson disease.

Don’t have time to watch a full video interview? Click here to check out our short videos!